Search
Trelnarizine
go.drugbank.com/drugs/DB21183ExperimentalThe usage of the INN stem '-rizine' in the name indicates that Trelnarizine is a antihistaminic/cerebral (or peripheral) vasodilator. Trelnarizine has a monoisotopic molecular weight of 464.23 Da.
Emorfazone
go.drugbank.com/drugs/DB21286ExperimentalThe usage of the INN stem '-azone' in the name indicates that Emorfazone is a anti-inflammatory analgesic, phenylbutazone derivative. Emorfazone has a monoisotopic molecular weight of 239.13 Da.
Fibracillin
go.drugbank.com/drugs/DB21302ExperimentalThe usage of the INN stem '-cillin' in the name indicates that Fibracillin is a antibiotic, 6-aminopenicillanic acid derivative. Fibracillin has a monoisotopic molecular weight of 545.14 Da.
Ipazilide
go.drugbank.com/drugs/DB21330ExperimentalThe usage of the INN stem '-ilide' in the name indicates that Ipazilide is a sematilide derivative class III antiarrhythmic. Ipazilide has a monoisotopic molecular weight of 390.24 Da.
Pidobenzone
go.drugbank.com/drugs/DB21369ExperimentalThe usage of the INN stem '-zone' in the name indicates that Pidobenzone is a anti-inflammatory analgesic, phenylbutazone derivative. Pidobenzone has a monoisotopic molecular weight of 221.07 Da.
Trifezolac
go.drugbank.com/drugs/DB21380ExperimentalThe usage of the INN stem '-ac' in the name indicates that Trifezolac is a anti-inflammatory agent, ibufenac derivative. Trifezolac has a monoisotopic molecular weight of 354.14 Da.
Pulrodemstat
go.drugbank.com/drugs/DB21497ExperimentalThe usage of the INN stem '-demstat' in the name indicates that Pulrodemstat is a Lysine-specific histone demethylase inhibitor. Pulrodemstat has a monoisotopic molecular weight of 451.18 Da.
Zavolosotine
go.drugbank.com/drugs/DB21531ExperimentalThe usage of the INN stem '-sotine' in the name indicates that Zavolosotine is a non-peptidic somatostatin receptor agonist. Zavolosotine has a monoisotopic molecular weight of 439.14 Da.
Ginisortamab
go.drugbank.com/drugs/DB18863InvestigationalGinisortamab is under investigation in clinical trial NCT04393298 (A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced
Ponazuril
go.drugbank.com/drugs/DB11452ExperimentalVet approvedPonazuril, sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.